NEUARTIGE TLR9-AGONISTEN
European patent · EP4087931 · In force
Register entry
- Publication number
- EP4087931
- Application number
- EP21738230
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- In force
- Specification
- Granted
- Filed
- Jan 8, 2021
- Published
- Nov 16, 2022
- Granted
- Dec 25, 2024
- Protection ends at the latest
- Jan 7, 2041
- Next annual fee due
- Jan 31, 2027
- IPC classes
- C12N 15/117 (2010.01)A61K 31/711 (2006.01)A61P 37/00 (2006.01)
- Priority
- JP 2020002715 10.01.2020
- PCT application
- PCT/JP2021/000543 08.01.2021
- PCT publication
- WO2021/141121 15.07.2021
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Feb 1, 2026
Change
Published in Swissreg on 01.02.2026
- Nov 5, 2025
Change
Published in Swissreg on 05.11.2025
- Feb 1, 2025
Change
Published in Swissreg on 01.02.2025
- Jan 13, 2025
Agent entered
- Representative
- Dennemeyer AG, Bahnhofstrasse 23, 6300 Zug
Published in Swissreg on 13.01.2025
- Dec 25, 2024
Granted
- Specification status
- Non-published patent application → Granted patent
- Status of protective title
- Initiated → Active
Published in Swissreg on 25.12.2024
Parties
Inventor
ESASHI Eiji
Tokyo 106-6015, JP
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.